BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Research Published In WOUNDS Demonstrates Benefits Of Continuous Bedside Pressure Mapping In A Pressure Ulcer Prevention Program In ICU, Wellsense Reveals


12/16/2013 8:57:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NASHVILLE, TN--(Marketwired - December 13, 2013) - New research published in WOUNDS, the most widely read, peer-reviewed journal focusing on wound care and wound research, demonstrated improved patient outcomes in the prevention of pressure ulcers for intensive care unit (ICU) patients with the use of Wellsense's M.A.P™, the first-ever continuous bedside pressure mapping system. The results of the study, "A Continuous Bedside Pressure Mapping System for Prevention of Pressure Ulcer Development in the ICU: A Retrospective Analysis" show real-time, ongoing pressure monitoring using M.A.P successfully aided in decreasing pressure ulcer occurrence in ICU patients by helping care providers effectively detect pressure and reposition patients within the context of existing National Pressure Ulcer Advisory Panel standardized guidelines.

During the two-month study period, only one out of 307 (0.3 %) patients using real-time continuous bedside pressure mapping (CBPM) technology developed a pressure ulcer compared to 16 out of 320 (5%) patients in the historical control group who were placed on the same beds without the M.A.P one year prior. In a survey of the medical ICU (MICU) care providers, 90% of respondents reported that continuous bedside pressure mapping contributed to improved pressure detection and relief, 88% indicated the system assisted them with repositioning protocols, and 84% reported the pressure map provided for more efficient and effective patient repositioning.

"Patient repositioning to offload high-pressure areas is an essential component of pressure ulcer prevention for bed-bound patients," said lead investigator Aamir Siddiqui, MD, Division Head of Plastic Surgery at Henry Ford Hospital in Detroit, MI. "In most settings, the quantity and quality of offloading and repositioning are difficult to measure but real-time continuous bedside pressure mapping unblinds caregivers to be able to see instant pressure distribution data and then off-load pressure accordingly."

The M.A.P's pressure sensing mat is made of an intelligent textile, which constantly measures pressure from thousands of discrete points. The variations in pressure across a patient's body are depicted on a monitor, using a color scheme to help caregivers visualize high (red) to low (blue) pressure points, which enables them to easily identify and minimize areas of high pressure.

"The instant feedback provided by the M.A.P allowed caregivers to really see for the first time whether or not a patient had been properly positioned," said Dr. Siddiqui. "The technology provided confidence and peace of mind that the areas of concern were appropriately off-loaded. This is an exciting opportunity for caregivers to learn optimal repositioning techniques and determine the best practices for minimizing pressure."

The Agency for Healthcare Research and Quality estimates 2.5 million people in the US develop pressure ulcers per year, 60,000 of whom die from complications. There is more than a half million US hospital admissions per year where pressure ulcers are either the primary or secondary diagnosis. The treatment of pressure ulcers costs the US healthcare system approximately $11.5 billion each year. The incremental cost of extended hospitalizations due to HAPUs is up to $120,000 per ulcer. Medicare has deemed HAPUs as a 'never event' and will not pay for these incremental costs.

About the M.A.P™

M.A.P™ is the first-ever, clinically proven, continuous bedside monitoring system that detects and depicts the variations in pressure across a patient's body, to aid in the prevention of hospital acquired pressure ulcers. Used on any existing bed, M.A.P™ enables caregivers to visualize real time pressure distribution data to guide effective patient repositioning. The live, color feedback provided by M.A.P™ empowers caregivers to easily identify early warning signs of risk to patient safety and has a demonstrated ability to improve upon a facility's pressure ulcer prevention program efforts.

About Wellsense

Wellsense was founded in 2009 to commercialize medical applications of a smart textile technology. The company's founders and management bring a strong track record of innovating and commercializing breakthrough technologies in consumer electronics and wound care. Wellsense is a privately held company. Additional information is available at www.themapsystem.com.

*The M.A.P. System from Wellsense is intended for bedside pressure mapping. M.A.P. is a "tool" and not a "treatment" which is used by physicians to assess and map bed pressure. The clinical data above discusses pressure ulcers and wound care. M.A.P. is not intended to treat, cure, prevent, mitigate or diagnose wounds or any specific disease. Physicians should use their best judgment and clinical experience when deciding when and where to use M.A.P. Full M.A.P. prescribing information is available at www.themapsystem.com.


Contact:
Brian Baxter for Wellsense
bbaxter@lazarpartners.com
646-871-8491



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES